First Time Loading...

Vanda Pharmaceuticals Inc
NASDAQ:VNDA

Watchlist Manager
Vanda Pharmaceuticals Inc Logo
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
Watchlist
Price: 4.82 USD 4.33% Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

VNDA Price Targets Summary
Vanda Pharmaceuticals Inc

Wall Street analysts forecast VNDA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VNDA is 5.36 USD with a low forecast of 5.3 USD and a high forecast of 5.51 USD.

VNDA Lowest Forecast
Wall Street Target
5.3 USD
10% Upside
VNDA Average Forecast
Wall Street Target
5.36 USD
11% Upside
VNDA Highest Forecast
Wall Street Target
5.51 USD
14% Upside
Lowest
Price Target
5.3 USD
10% Upside
Average
Price Target
5.36 USD
11% Upside
Highest
Price Target
5.51 USD
14% Upside
Vanda Pharmaceuticals Inc Competitors:
Price Targets
300439
MedicalSystem Biotechnology Co Ltd
143% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
41% Upside
1801
Innovent Biologics Inc
42% Upside
ALKS
Alkermes Plc
46% Upside
300439
MedicalSystem Biotechnology Co Ltd
143% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
41% Upside
1801
Innovent Biologics Inc
42% Upside
ALKS
Alkermes Plc
46% Upside
KRRO
Korro Bio Inc
118% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
7% Upside
MGNX
MacroGenics Inc
71% Upside
ALGEN
Genoway SA
63% Upside

Revenue
Forecast

Revenue Estimate
Vanda Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 7%. The projected CAGR for the next 2 years is 11%.

7%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Vanda Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

See Also

Summary
VNDA intrinsic value, competitors valuation, and company profile.
DCF Valuation
VNDA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VNDA stock valuation using valuation multiples.
Wall Street Estimates
VNDA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VNDA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VNDA's stock price target?
Price Target
5.36 USD

According to Wall Street analysts, the average 1-year price target for VNDA is 5.36 USD with a low forecast of 5.3 USD and a high forecast of 5.51 USD.

What is Vanda Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Vanda Pharmaceuticals Inc's revenue is 7%. The projected CAGR for the next 2 years is 11%.

ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.